Sanofi expands its social commitments, creates nonprofit unit to provide poorest countries with access to essential medicines
April 07 2021: "In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement...
CDC Issues Updated Guidance on Travel for Fully Vaccinated People
April 2, 2021: "The Centers for Disease Control and Prevention (CDC) updated its travel guidance for fully vaccinated people to reflect the...
FDA Makes Two Revisions to Moderna COVID-19 Vaccine Emergency Use Authorization
April 01, 2021: "The U.S. FDA announced two revisions regarding the number of doses per vial available for the Moderna COVID-19 Vaccine....
FDA is Investigating Reports of Infections Associated with Reprocessed Urological Endoscopes
April 01, 2021: "The U.S.FDA announced it is investigating numerous medical device reports (MDRs) describing patient infections and other possible contamination issues associated with...
Positive results for Pfizer/BioNTech’s COVID-19 vaccine in 12-16 year olds
April 01, 2021: "Pfizer Inc. and BioNTech SE announced updated topline results from analysis of 927 confirmed symptomatic cases of COVID-19 observed in...
FDA approves Sarclisa® with carfilzomib & dexamethasone for multiple myeloma
March 31, 2021: "The U.S.FDA has approved Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone (Kd), for the treatment of adult patients with relapsed...
FDA Continues to Advance Over-the Counter and Other Screening Test Development
March 31, 2021: "Following recent U.S. FDA actions to support test development, the FDA took swift action this week to get more...
Roche launches Elecsys Epstein-Barr Virus immunoassay panel to improve EBV infection staging
March 31, 2021: "Roche announced that the Elecsys® EBV panel has launched in countries accepting the CE Mark.
EMA Validates BMS Opdivo as Adjuvant Treatment for Muscle-Invasive Urothelial Carcinoma
March 29, 2021: "Bristol Myers Squibb announced that the European Medicines Agency (EMA) has validated its type II variation application for Opdivo (nivolumab) for...
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine
March 31 2021: "Sanofi announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site...
FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings
March 30, 2021: "The U.S. Food and Drug Administration announced it is allowing the use of the Binx Health IO CT/NG Assay...
Incyte’s Pemazyre® aothorized by EU for Advanced or Metastatic Cholangiocarcinoma
March 29, 2021: "Incyte announced that the European Commission (EC) has approved Pemazyre® (pemigatinib) for the treatment of adults with locally advanced or...
Most Read
Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia
April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.
GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures
April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...
JCVI issues new advice on COVID-19 vaccination for pregnant women
April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.
